This is an NIH/NCI R01 research grant for advanced pre-clinical work on nanotechnology-based cancer diagnostics and therapeutics, aimed at moving experimental nanomedicines toward clinical development. It suits small biotech businesses, universities, and nonprofits with an existing nanoparticle cancer program; retail, finance, housing, or any organization without active nanotech cancer R&D should not bother applying.
| Industry | Estimated fit |
|---|---|
| Healthcare & BiotechMatches your industry (clinical) | 81 |
| Technology & SoftwareMatches your industry (technology, tech) | 79 |
| Agriculture & FarmingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Arts & CultureLimit: Nothing in this notice points to arts & culture | 54 |
| Construction & InfrastructureLimit: Nothing in this notice points to construction & infrastructure | 54 |
| Education & TrainingLimit: Nothing in this notice points to education & training | 54 |
| Industry | Estimated fit |
|---|---|
| Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech | 54 |
| Environment & ConservationLimit: Nothing in this notice points to environment & conservation | 54 |
| Finance & BankingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Food & BeverageLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Housing & Real EstateLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| ManufacturingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Retail & E-CommerceLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Social Services & NonprofitLimit: Nothing in this notice points to social services & nonprofit | 54 |
| Transportation & LogisticsLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.
NIH/NCI R01 grants for advanced pre-clinical research translating nanotechnology-based cancer diagnostics and therapeutics toward clinical development. Eligible applicants include small businesses, other for-profits, universities, nonprofits, state/local/tribal governments, and other organizations; foreign entities are not eligible.
Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encourages applications for advanced pre-clinical research, supporting translation of nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards are designed to mature experimental nanomedicines relying on nanoparticles and nano-devices which demonstrate strong potential to improve cancer treatment effectiveness due to the combination of nanoparticle/nano-device structural design and/or therapeutic/diagnostic cargo which is delivered. TTNCI awards are expected to enable further development of proposed nanotechnology-based interventions to the stage in which they could continue on a developmental path towards the NCI Experimental Therapeutics (NExT) and other NCI translational programs.
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Topics
Open opportunities funding similar work, from the same funder or in the same place.
NIH BRAIN Initiative grants to develop tools and computational models for high-resolution, synchronous measurement of complex behaviors alongside neural activity in humans and other species. Eligible applicants include…
NIH/NCI K99/R00 career-development award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent tenure-track faculty positions; requires the candidate to lead an…
NIH/NCI UH3 cooperative agreement to clinically validate established molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, or treatment response using specimens from…
NIH/NCI K99/R00 award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent faculty careers. The applicant is typically the sponsoring institution; eligible…
NIH/NCI cooperative agreement (UH2/UH3) funding validation of molecular, cellular, and imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Open to universities,…
NIH/NCI program funding revision applications to adapt and clinically validate molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction.…